Transaction in Own Shares

RNS Number : 7522A

GlaxoSmithKline PLC

04 February 2011

 

GlaxoSmithKline plc (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 6 May 2010 it purchased 898,126 of its Ordinary shares of 25 pence each ("shares") on 4 February 2011.

The highest price paid per share was 1,174.5 pence per share.

The lowest price paid per share was 1,165.0 pence per share.

The Company intends to hold these shares in Treasury.

Including shares which have been purchased but not yet settled, the Company holds 475,092,284 of its shares in Treasury, representing 9.14% of the total voting rights in the Company.

The Company has 5,195,593,373 shares in issue (excluding Treasury shares). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

END

 

 

POSLLFFTFLISIIL